Ohio's Board of Pharmacy has banned the use of the anti-malarial drug hydroxychloroquine for the treatment or prevention of COVID-19.
A new regulation came into effect on July 30, 2020 that prohibits pharmacies, clinics and other medical institutions from dispensing or selling hydroxychloroquine, and the related drug chloroquine, for these purposes, although there are certain exceptions, for example, if the prescription is for a pet or the board's director approves a specific case.
Furthermore, patients enrolled in any approved clinical trials evaluating the drug for the treatment of prevention of COVID-19 will also still be able to access the medication if they have the correct documentation.
Please select this link to read the complete article from Newsweek.